Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardima submits cardiac ablation system 510(k):

This article was originally published in Clinica

Executive Summary

Cardima has submitted to the US FDA a 510(k) marketing application for a surgical ablation system for use in minimally invasive cardiac surgery. The system uses commercially available electro-surgical radiofrequency (RF) generators, a Cardima surgical probe employing multi-electrode linear array microcatheter technology, and a power-channelling device, INTELLITEMP, which allows the surgeon to apply RF energy to any or all of the individual electrodes on the probe. The Fremont, California firm said that the product was part of its "atrial fibrillation strategy" to develop less invasive tools for treating irregular heart rhythms.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067564

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel